High-Throughput Alternative Splicing Detection In Patients With Non-Small Cell Lung Cancer Treated By Bevacizumab/erlotinib

被引：0
|
作者：
Baty, F. [1 ]
Brutsche, M. [1 ]
机构：
[1] Cantonal Hosp St Gallen, St Gallen, Switzerland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3476
引用
收藏
页数：1
相关论文
共 50 条
  • [1] High-throughput detection of alternative splicing in patients with non-small cell lung cancer treated by bevacizumab/erlotinib
    Baty, Florent
    Brutsche, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] VeriStrat predicts survival in patients with non-small cell lung cancer (NSCLC) treated with erlotinib and bevacizumab
    Salmon, J. S.
    Dang, T. P.
    Billheimer, D.
    Roder, H.
    Grigorieva, J.
    Tsypin, M.
    Herbst, R. S.
    Tsao, A. S.
    Tran, H.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] VeriStrat® classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab
    Carbone, David P.
    Salmon, J. Stuart
    Billheimer, Dean
    Chen, Heidi
    Sandler, Alan
    Roder, Heinrich
    Roder, Joanna
    Tsypin, Maxim
    Herbst, Roy S.
    Tsao, Anne S.
    Tran, Hai T.
    Dang, Thao P.
    LUNG CANCER, 2010, 69 (03) : 337 - 340
  • [4] Combination of erlotinib and bevacizumab in non small cell lung cancer patients
    Boutsikou, Efimia
    Kontakiotis, Theodoros
    Zarogoulidis, Pavlos
    Pataka, Paraskevi
    Zarogoulidis, Kostas
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [5] Effect of erlotinib plus bevacizumab on brain metastases in patients with non-small cell lung cancer
    Chikaishi, Yasuhiro
    Kanayama, Masatoshi
    Taira, Akihiro
    Nabe, Yusuke
    Shinohara, Shinji
    Kuwata, Taiji
    Takenaka, Masaru
    Oka, Soichi
    Hirai, Ayako
    Kuroda, Koji
    Imanishi, Naoko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (20)
  • [6] Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
    Boutsikou, Eftimia
    Kontakiotis, Theodoros
    Zarogoulidis, Paul
    Darwiche, Kaid
    Eleptheriadou, Ellada
    Porpodis, Konstantinos
    Galaktidou, Grammati
    Sakkas, Leonidas
    Hohenforst-Schmidt, Wolfgang
    Tsakiridis, Kosmas
    Karaiskos, Theodoros
    Zarogoulidis, Konstantinos
    ONCOTARGETS AND THERAPY, 2013, 6 : 125 - 134
  • [7] High-throughput Molecular Genotyping for Small Biopsy Samples in Advanced Non-small Cell Lung Cancer Patients
    Maeng, Chi Hoon
    Lee, Ho Yun
    Kim, Young Wook
    Choi, Moon Ki
    Hong, Jung Yong
    Jung, Hyun Ae
    Lee, Kyung Soo
    Kim, Hojoong
    Kwon, O. Jung
    Sun, Jong-Mu
    Ahn, Jin Seok
    Park, Keunchil
    Um, Sang-Won
    Ahn, Myung-Ju
    ANTICANCER RESEARCH, 2013, 33 (11) : 5127 - 5133
  • [8] Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer
    Zhou, Songwen
    Ren, Shengxiang
    Yan, Lianghua
    Zhang, Ling
    Tang, Liang
    Zhang, Jie
    Zhou, Caicun
    RESPIROLOGY, 2009, 14 (05) : 709 - 715
  • [9] PHASE II TRIAL OF ERLOTINIB IN PREVIOUSLY TREATED PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Okano, Yoshio
    Shinohara, Tsutomu
    Machida, Hisanori
    Hatakeyama, Nobuo
    Takeuchi, Eiji
    Doi, Hiroyuki
    Kubota, Tetsuya
    Yokoyama, Akihito
    Ogushi, Fumitaka
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1175 - S1176
  • [10] Bevacizumab in Non-Small Cell Lung Cancer
    Francesco Di Costanzo
    Francesca Mazzoni
    Marinella Micol Mela
    Lorenzo Antonuzzo
    Daniele Checcacci
    Matilde Saggese
    Federica Di Costanzo
    Drugs, 2008, 68 : 737 - 746
12345